Novartis Investigative Site

Kampala 101

1 studies enrolling now · 1 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) — Recruiting now